FORMULATION AND EVALUATION OF NON EFFERVESCENT FLOATING TABLETS OF CEFUROXIME AXETIL

被引:1
作者
Ratnamala, K. V. [1 ]
Anisha, Y. [1 ]
机构
[1] RBVRR Womens Coll Pharm, Dept Pharmaceut, Hyderabad, Telangana, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2015年 / 6卷 / 07期
关键词
Cefuroxime Axetil; Melt granulation; Meltable binders; gastric residence time; Non Effervescent floating; Buoyancy time;
D O I
10.13040/IJPSR.0975-8232.6(7).2864-75
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this work was to develop non effervescent floating tablets by Melt granulation technique. Cefuroxime axetil is having shorter half life of 80 min and hydrolyzed by intestinal esterase to the non absorbable cefuroxime in the gut lumen and is, therefore, suspected as a possible cause of incomplete bioavailability. So there is a need to increase the gastric residence time of the drug. These tablets were prepared by different meltable binders such as paraffin wax, bees wax and carnauba wax as release retardants. Various formulations have been developed by varying concentration of waxes, buoyancing agent and disintegrating agent. The FTIR spectrum indicated the stability and compatability of drug and excipients. All the formulations (F1 to F9) were evaluated for weight variation, hardness, friability, buoyancy studies and In-vitro drug release studies. Among all the formulations, dissolution studies data indicated that F9 formulation exhibited good drug release 0f 91.67% and has shown floating time more than 24hrs with a lag time of 30 min. The mechanism of drug release of NEF tablets of Cefuroxime Axetil was determined by the application of Korsmeyer-Peppas model, Higuchi's model, Zero order and first order kinetics. From the drug release plots it was observed that the drug release was following zero order kinetics and non - fickian diffusion (n value 0.5 to 1) fitting in to Korsmeyer-Peppas equation. This indicates that drug release depends on erosion of waxes.
引用
收藏
页码:2864 / 2875
页数:12
相关论文
共 30 条
  • [1] Agrawal R, 2011, INT J PHARM FRONT RE, V1, P65
  • [2] Formulation, Characterization and Physicochemical Evaluation of Ranitidine Effervescent Tablets
    Aslani, Abolfazl
    Jahangiri, Hajar
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2013, 3 (02) : 315 - 322
  • [3] Banker GS, 2002, MODERN PHARM
  • [4] Bavisia K. D., 2012, INT J PHARM RES BIOS, V1, P184
  • [5] Brahmanker D.M., 1995, BIOPHARMACEUTICS PHA
  • [6] Dhumal RS, 2006, J SCI IND RES INDIA, V65, P812
  • [7] Dixit N, 2011, J CURR PHARM RES, V7, P6
  • [8] Dwivedi S, 2011, INT J RES PHARM BIOM, V2, P1413
  • [9] Formulation and Evaluation of Non-Effervescent Floating Tablets of Losartan Potassium
    Getyala, Anil
    Gangadharappa, H. V.
    Prasad, M. Sarat Chandra
    Reddy, M. Praveen Kumar
    Kumar, T. M. Pramod
    [J]. CURRENT DRUG DELIVERY, 2013, 10 (05) : 620 - 629
  • [10] Gudigennavar A. S., 2013, African Journal of Pharmacy and Pharmacology, V7, P1332